LG AI Research and D&D Pharmatech sign agreement for oral peptide drugs

LG AI Research and D&D Pharmatech have entered into an agreement to collaborate on the development of next-generation oral peptide drugs, the companies announced following a signing ceremony held at the LG Twin Towers in Yeouido, Seoul.